home > epc

European Pharmaceutical Contractor


Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry – giving its pharma, biotech and CRO readership expert insight and analysis on the sponsor-service provider landscape.

EPC focuses on key trends, concerns and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis on building and managing effective collaborations.

Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.


For further information please contact:

Nick Matthews

Rupert Gilbey

We're also on Twitter! Follow us @EPCmagazine

The latest digital edition of EPC can be viewed here

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

Featured in this issue
Risk Management

Progress Report

EPC offers a run-down of specific measures being implemented by the EMA to maximise the efficiency of the EudraVigilance safety reporting system for adverse events, following a significant decline in signals in 2014.
Legal & Regulatory
Patent Protection

Optional Extras

It is uncertain times for patent portfolios in Europe, with pharma companies large and small working out whether to opt in or out of the Unifi ed Patent Court system, coming in 2017. The risks, rewards and – crucially – costs of the new regime must all be weighed up, says Paul Harris at Pillsbury Law.
  Marketplace & Business
CRO Growth

Deal Me In

Contract research continues to thrive as CROs strengthen their R&D services and sponsors tighten their budgets. Growth is surging this year and predicted to at least the end of the decade, driven by the big players and market consolidation. EPC has more.


Published quarterly in
February, May,
August and November

Banner of ESMO.EPC on Samedan
Industry Events

8th Annual Pre-Filled Syringes Conference and Exhibition

27-28 January 2016, London, United Kingdom

SMi’s Pre-Filled Syringes conference returns to London, in January 2016, as it looks beyond upcoming obstacles which will help delegates prepare for better PFS solutions. With a selected 100+ representatives from the world’s leading Pharmaceutical and Biotechnology businesses, attendees will learn the A-Z journey of PFS as well as provide the chance to bridge the technical and commercial gap, helping to stay ahead of competition.
More info >>

News and Press Releases

CK to Attend PCT Event in Hamburg, Germany

Industry professionals searching for a new role or hiring managers looking to discuss their recruitment needs can meet with CK Clinical's specialist clinical operations recruiter at the upcoming PCT Hamburg show.
More info >>

air transport logo


White Papers

Changing Structural Landscape for Comparator Drug Supply

ADAllen Pharma

TransCelerate Biopharma is focused on advancing innovation in R&D, identifying and solving common R&D challenges and further improving patient safety, with the goal of delivering more high quality medicines to patients. In 2013, they announced its Clinical Trial Comparator Network initiative to show a mutual commitment to offer secure and rapid supply of comparator drug products. The aim of this article is to unpack the section on 'Comparator Drugs' and analyse the rationale for attempting to achieve their objectives.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement